Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaxone Dosing Satisfaction in RRMS
NCT02499900Phase 4Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Aug 2015
- Primary completion
- Jan 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 16
01
Overview
A Phase 4 trial of glatiramer acetate in multiple sclerosis (MS), sponsored by Teva Pharmaceutical Industries Ltd.. Started Aug 2015; status: completed.
02
Drugs
glatiramer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02499900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02499900.